LMMYOTCServices-Educational ServicesFiscal year ends May 31
Exousia Bio, Inc.
Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Jun 16, 2026
$0.01−0.00 (-18.29%)
Close on Oct 19, 2026
- Market cap
- $175.47K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.1663 (−92.08%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Exousia Bio, Inc. saw revenue fall 100.0% to $0 over the twelve months to Feb 28, 2026.
Revenue
$0
-100.0% vs. a year earlier
EPS, diluted
$0.00
-100.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Feb 28, 2026
Valuation
- Market cap
- $175.47K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.01
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $0
- Net income
- -$80.16K
- EPS, diluted
- $0.00
- Book value per share
- $1.78
- Diluted shares
- 12M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$0-100.0% YoY
Gross profit
-$69.36K
Operating income
–
Net income
-$80.16K-160.4% YoY
EPS, diluted
$0.00-100.0% YoY
Reported periodTrailing twelve months